Clarithromycin resistance in Helicobacter pylori infection: does it matter?
Fock
K M
KM
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D017291:Clarithromycin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial / Q000235:genetics; D004359:Drug Therapy, Combination; D005798:Genes, Bacterial / Q000235:genetics; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D008826:Microbial Sensitivity Tests; D015337:Multicenter Studies as Topic; D009154:Mutation; D015995:Prevalence; D054328:Proton Pump Inhibitors; D012329:RNA, Bacterial / Q000235:genetics; D013997:Time Factors
D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors; D012329:RNA, Bacterial; D017291:Clarithromycin